Bioventus Inc.BVSNASDAQ
Loading
Stockholders Equity Over TimeStable
Percentile Rank67
3Y CAGR-17.3%
5Y CAGR+5.3%
Studio
Year-over-Year Change

Net worth of the company (assets minus liabilities)

3Y CAGR
-17.3%/yr
vs +22.3%/yr prior
5Y CAGR
+5.3%/yr
Recent deceleration
Acceleration
-39.6pp
Decelerating
Percentile
P67
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive growthStable
PeriodValueYoY Change
2025$184.10M+24.4%
2024$147.94M-14.8%
2023$173.59M-46.6%
2022$325.24M-29.1%
2021$458.92M+222.6%
2020$142.24M-0.5%
2019$142.98M-1.6%
2018$145.27M-24.5%
2015$192.34M+8.4%
2014$177.49M-